The studies using transgenic mice overexpressing Hgf and hepatocyte-specific c-met knockout mice, indicate the protective role of the HGF-MET pathway in the development of NAFLD (13, 14). Here, MET is linked to metabolic dysfunction-associated steatotic liver disease.